ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients

ADAM17 Genetic Variants and the Response of TNF-α Inhibitor in Rheumatoid Arthritis Patients

Hyun Jeong Kim, 1,* Nga Thi Trinh, 1,* Yunjeong Choi, 1 Woorim Kim, 1 Kyung Hyun Min, 1 Sang Oh Kang, 1 Joo Hee Kim, 2 Hyoun-Ah Kim, 3 Ju-Yang Jung, 3 In Ah Choi, 4 Kyung Eun Lee 1 1College of Pharmacy, Chungbuk National University, Cheongju-si, Republic of Korea; 2College of Pharmacy, Ajou Univer...

Full description

Bibliographic Details
Main Authors: Kim HJ, Trinh NT, Choi Y, Kim W, Min KH, Kang SO, Kim JH, Kim HA, Jung JY, Choi IA, Lee KE
Format: Article
Language:English
Published: Dove Medical Press 2020-03-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
rheumatoid arthritis
tnf-α inhibitor
adam17
single nucleotide polymorphism
Online Access:https://www.dovepress.com/adam17-genetic-variants-and-the-response-of-tnf-alpha-inhibitor-in-rhe-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/adam17-genetic-variants-and-the-response-of-tnf-alpha-inhibitor-in-rhe-peer-reviewed-article-PGPM

Similar Items